Mar 23, 2026 7:11 PMPublished Mar 23, 2026 7:11 PM
Abandoning established pharmaceutical products for a "staking-driven revenue model" based on digital tokens isn't a visionary pivot, but a desperate gamble that replaces tangible value with speculative protocol activity. How can a company generate sustainable returns without traditional business operations? This summary was generated by AI